These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 23165968

  • 1. MRI tracking of transplanted iron-labeled mesenchymal stromal cells in an immune-compromised mouse model of critical limb ischemia.
    Noad J, Gonzalez-Lara LE, Broughton HC, McFadden C, Chen Y, Hess DA, Foster PJ.
    NMR Biomed; 2013 Apr; 26(4):458-67. PubMed ID: 23165968
    [Abstract] [Full Text] [Related]

  • 2. Long-term/bioinert labeling of rat mesenchymal stem cells with PVA-Gd conjugates and MRI monitoring of the labeled cell survival after intramuscular transplantation.
    Tachibana Y, Enmi J, Agudelo CA, Iida H, Yamaoka T.
    Bioconjug Chem; 2014 Jul 16; 25(7):1243-51. PubMed ID: 24927375
    [Abstract] [Full Text] [Related]

  • 3. Magnetic resonance imaging of single co-labeled mesenchymal stromal cells after intracardial injection in mice.
    Salamon J, Wicklein D, Didié M, Lange C, Schumacher U, Adam G, Peldschus K.
    Rofo; 2014 Apr 16; 186(4):367-76. PubMed ID: 24683169
    [Abstract] [Full Text] [Related]

  • 4. Magnetic resonance imaging with superparamagnetic iron oxide fails to track the long-term fate of mesenchymal stem cells transplanted into heart.
    Ma N, Cheng H, Lu M, Liu Q, Chen X, Yin G, Zhu H, Zhang L, Meng X, Tang Y, Zhao S.
    Sci Rep; 2015 Mar 12; 5():9058. PubMed ID: 25762186
    [Abstract] [Full Text] [Related]

  • 5. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart.
    Terrovitis J, Stuber M, Youssef A, Preece S, Leppo M, Kizana E, Schär M, Gerstenblith G, Weiss RG, Marbán E, Abraham MR.
    Circulation; 2008 Mar 25; 117(12):1555-62. PubMed ID: 18332264
    [Abstract] [Full Text] [Related]

  • 6. Angiogenic properties of mesenchymal stem cells in a mouse model of limb ischemia.
    Martins L, Martin PK, Han SW.
    Methods Mol Biol; 2014 Mar 25; 1213():147-69. PubMed ID: 25173381
    [Abstract] [Full Text] [Related]

  • 7. Tracking the fate of stem cell implants with fluorine-19 MRI.
    Gaudet JM, Ribot EJ, Chen Y, Gilbert KM, Foster PJ.
    PLoS One; 2015 Mar 25; 10(3):e0118544. PubMed ID: 25767871
    [Abstract] [Full Text] [Related]

  • 8. In vitro labeling and MRI of mesenchymal stem cells from human umbilical cord blood.
    Ju S, Teng G, Zhang Y, Ma M, Chen F, Ni Y.
    Magn Reson Imaging; 2006 Jun 25; 24(5):611-7. PubMed ID: 16735183
    [Abstract] [Full Text] [Related]

  • 9. Viability and MR detectability of iron labeled mesenchymal stem cells used for endoscopic injection into the porcine urethral sphincter.
    Will S, Martirosian P, Eibofner F, Schick F, Bantleon R, Vaegler M, Grözinger G, Claussen CD, Kramer U, Schmehl J.
    NMR Biomed; 2015 Aug 25; 28(8):1049-58. PubMed ID: 26147577
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of cell tracking effects for transplanted mesenchymal stem cells with jetPEI/Gd-DTPA complexes in animal models of hemorrhagic spinal cord injury.
    Liu Y, He ZJ, Xu B, Wu QZ, Liu G, Zhu H, Zhong Q, Deng DY, Ai H, Yue Q, Wei Y, Jun S, Zhou G, Gong QY.
    Brain Res; 2011 May 19; 1391():24-35. PubMed ID: 21420939
    [Abstract] [Full Text] [Related]

  • 11. Noninvasive in vivo tracking of mesenchymal stem cells and evaluation of cell therapeutic effects in a murine model using a clinical 3.0 T MRI.
    Drey F, Choi YH, Neef K, Ewert B, Tenbrock A, Treskes P, Bovenschulte H, Liakopoulos OJ, Brenkmann M, Stamm C, Wittwer T, Wahlers T.
    Cell Transplant; 2013 May 19; 22(11):1971-80. PubMed ID: 23050950
    [Abstract] [Full Text] [Related]

  • 12. In vitro labeling of human umbilical cord mesenchymal stem cells with superparamagnetic iron oxide nanoparticles.
    Hu SL, Zhang JQ, Hu X, Hu R, Luo HS, Li F, Xia YZ, Li JT, Lin JK, Zhu G, Feng H.
    J Cell Biochem; 2009 Oct 01; 108(2):529-35. PubMed ID: 19623584
    [Abstract] [Full Text] [Related]

  • 13. Comparison of treatments of peripheral arterial disease with mesenchymal stromal cells and mesenchymal stromal cells modified with granulocyte and macrophage colony-stimulating factor.
    da Cunha FF, Martins L, Martin PK, Stilhano RS, Paredes Gamero EJ, Han SW.
    Cytotherapy; 2013 Jul 01; 15(7):820-9. PubMed ID: 23660332
    [Abstract] [Full Text] [Related]

  • 14. In vivo MRI tracking of iron oxide nanoparticle-labeled human mesenchymal stem cells in limb ischemia.
    Li XX, Li KA, Qin JB, Ye KC, Yang XR, Li WM, Xie QS, Jiang ME, Zhang GX, Lu XW.
    Int J Nanomedicine; 2013 Jul 01; 8():1063-73. PubMed ID: 23515426
    [Abstract] [Full Text] [Related]

  • 15. In vivo monitoring of magnetically labeled mesenchymal stem cells homing to rabbit hepatic VX2 tumors using magnetic resonance imaging.
    Qin Y, Zhuo L, Cai J, He X, Liu B, Feng C, Zhang L.
    Mol Med Rep; 2018 Jan 01; 17(1):452-458. PubMed ID: 29115453
    [Abstract] [Full Text] [Related]

  • 16. Trimodal Cell Tracking In Vivo: Combining Iron- and Fluorine-Based Magnetic Resonance Imaging with Magnetic Particle Imaging to Monitor the Delivery of Mesenchymal Stem Cells and the Ensuing Inflammation.
    Sehl OC, Makela AV, Hamilton AM, Foster PJ.
    Tomography; 2019 Dec 01; 5(4):367-376. PubMed ID: 31893235
    [Abstract] [Full Text] [Related]

  • 17. Monitoring bone marrow-originated mesenchymal stem cell traffic to myocardial infarction sites using magnetic resonance imaging.
    Yang Y, Schumacher A, Yang Y, Liu J, Shi X, Hill WD, Hu TC.
    Magn Reson Med; 2011 May 01; 65(5):1430-6. PubMed ID: 21287590
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of intracellular labeling with micron-sized particles of iron oxide (MPIOs) as a general tool for in vitro and in vivo tracking of human stem and progenitor cells.
    Boulland JL, Leung DS, Thuen M, Vik-Mo E, Joel M, Perreault MC, Langmoen IA, Haraldseth O, Glover JC.
    Cell Transplant; 2012 May 01; 21(8):1743-59. PubMed ID: 22490338
    [Abstract] [Full Text] [Related]

  • 19. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F, Zhu X, Hu XQ, Fang ZF, Tang L, Lu XL, Zhou SH.
    Int J Mol Med; 2013 Feb 01; 31(2):484-92. PubMed ID: 23229021
    [Abstract] [Full Text] [Related]

  • 20. In vivo tracking and fate of intra-articularly injected superparamagnetic iron oxide particle-labeled multipotent stromal cells in an ovine model of osteoarthritis.
    Delling U, Brehm W, Metzger M, Ludewig E, Winter K, Jülke H.
    Cell Transplant; 2015 Feb 01; 24(11):2379-90. PubMed ID: 25506789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.